Vamil Divan
Stock Analyst at Guggenheim
(4.81)
# 488
Out of 4,587 analysts
976
Total ratings
58.7%
Success rate
13.1%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterated: Buy | $270 | $255.82 | +5.54% | 54 | Jul 23, 2026 | |
| INSM Insmed | Maintained: Buy | $207 | $101.49 | +103.96% | 18 | Jul 21, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $65 | $57.28 | +13.48% | 29 | Jul 21, 2026 | |
| VALN Valneva SE | Maintained: Buy | $11 | $5.09 | +116.27% | 9 | Jul 21, 2026 | |
| ELOX Eloxx Pharmaceuticals | Initiated Coverage: Buy | $43 | $13.30 | +223.31% | 1 | Jul 19, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $145 | $129.79 | +11.72% | 50 | Jul 17, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Buy | $124 | $80.43 | +54.17% | 21 | Jul 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $340 → $343 | $387.64 | -11.52% | 8 | Jul 10, 2026 | |
| PFE Pfizer | Maintained: Buy | $36 → $35 | $24.91 | +40.51% | 118 | Jul 10, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $249 → $261 | $257.41 | +1.39% | 129 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $76 | $33.05 | +129.95% | 15 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $3.73 | -19.57% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $5.30 | +598.11% | 8 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $7.64 | +96.34% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $47 | $20.00 | +135.00% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $26.06 | +65.00% | 12 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.54 | +98.56% | 9 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 38.00 | kr 11.02 | +244.83% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.41 | +134.60% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $1.58 | n/a | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.22 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | €14.00 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.1783 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $26 | $5.35 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,154.97 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $112.64 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.42 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $234.64 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.01 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $26.55 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $50.03 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $2.72 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $83.30 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $738.34 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $139 | $42.89 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $481.70 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $16.85 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $34.52 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $185.50 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $27.99 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $33.43 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.36 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.73 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $35.41 | n/a | 55 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $59 → $55 | $64.86 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $27.64 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $95.21 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $13.19 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $207.93 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $0.699 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $5.37 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $205.09 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $131.28 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $138.71 | n/a | 1 | Mar 5, 2013 |
Johnson & Johnson
Jul 23, 2026
Reiterated: Buy
Price Target: $270
Current: $255.82
Upside: +5.54%
Insmed
Jul 21, 2026
Maintained: Buy
Price Target: $207
Current: $101.49
Upside: +103.96%
Travere Therapeutics
Jul 21, 2026
Reiterated: Buy
Price Target: $65
Current: $57.28
Upside: +13.48%
Valneva SE
Jul 21, 2026
Maintained: Buy
Price Target: $11
Current: $5.09
Upside: +116.27%
Eloxx Pharmaceuticals
Jul 19, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $13.30
Upside: +223.31%
Merck & Co.
Jul 17, 2026
Maintained: Buy
Price Target: $145
Current: $129.79
Upside: +11.72%
ANI Pharmaceuticals
Jul 14, 2026
Maintained: Buy
Price Target: $124
Current: $80.43
Upside: +54.17%
Amgen
Jul 10, 2026
Maintained: Hold
Price Target: $340 → $343
Current: $387.64
Upside: -11.52%
Pfizer
Jul 10, 2026
Maintained: Buy
Price Target: $36 → $35
Current: $24.91
Upside: +40.51%
AbbVie
Jul 8, 2026
Reiterated: Buy
Price Target: $249 → $261
Current: $257.41
Upside: +1.39%
Jul 8, 2026
Reiterated: Buy
Price Target: $56 → $76
Current: $33.05
Upside: +129.95%
Jul 1, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $3.73
Upside: -19.57%
Jun 30, 2026
Maintained: Buy
Price Target: $37
Current: $5.30
Upside: +598.11%
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $7.64
Upside: +96.34%
Jun 1, 2026
Reiterated: Buy
Price Target: $32 → $47
Current: $20.00
Upside: +135.00%
May 28, 2026
Reiterated: Buy
Price Target: $43
Current: $26.06
Upside: +65.00%
May 12, 2026
Reiterated: Buy
Price Target: $11
Current: $5.54
Upside: +98.56%
May 6, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: kr 11.02
Upside: +244.83%
Mar 20, 2026
Maintained: Buy
Price Target: $8
Current: $3.41
Upside: +134.60%
Jul 13, 2025
Maintained: Buy
Price Target: $6 → $7
Current: $1.58
Upside: n/a
May 29, 2025
Maintained: Hold
Price Target: n/a
Current: $10.22
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: €14.00
Upside: n/a
May 6, 2024
Maintained: Hold
Price Target: n/a
Current: $0.1783
Upside: n/a
Jun 15, 2023
Maintained: Buy
Price Target: $50 → $26
Current: $5.35
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,154.97
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $112.64
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $8.42
Upside: n/a
Jun 27, 2022
Maintained: Buy
Price Target: $49
Current: $234.64
Upside: n/a
Jun 21, 2022
Maintained: Buy
Price Target: $15
Current: $6.01
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $26.55
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $50.03
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: $20 → $10
Current: $2.72
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $83.30
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $738.34
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $139
Current: $42.89
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $481.70
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $16.85
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $34.52
Upside: n/a
May 4, 2022
Maintained: Hold
Price Target: $95
Current: $185.50
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $27.99
Upside: n/a
May 7, 2021
Maintained: Buy
Price Target: $37
Current: $33.43
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.36
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $3.73
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $35.41
Upside: n/a
May 29, 2019
Maintained: Hold
Price Target: $59 → $55
Current: $64.86
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $27.64
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $95.21
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $13.19
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $207.93
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $0.699
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $5.37
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $205.09
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $131.28
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $138.71
Upside: n/a